Physician profile
Jon Yenari
NPI 1396718656
$928.42
in general payments reported to CMS, 2019-2025
15 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2021: $297 · 2022: $260 · 2024: $30.67 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.31 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.52 | 2019-2022 | |
| Therapeuticsmd, INC. | $140.84 | 2019 | |
| Myovant Sciences INC. | $130.96 | 2022 | |
| Smith+Nephew, INC. | $122.05 | 2025 | Pico |
| Evofem Biosciences, INC. | $84.49 | 2021-2022 | |
| Intuitive Surgical, INC. | $60.30 | 2021 | |
| Medtronic USA, INC. | $46.92 | 2019 | |
| Pfizer INC. | $34.82 | 2021 | |
| Hologic Sales and Service, LLC | $33.09 | 2022 | |
| Coopersurgical, INC. | $32.79 | 2022-2025 | Sos |
| Baxter Healthcare | $30.60 | 2021 | |
| Coloplast Corp | $21.40 | 2021 | |
| Exeltis, USA INC. | $17.97 | 2022 | |
| Astellas Pharma US INC | $17.32 | 2024 | Veozah |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Yenari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.